Table 3.
| Variable | GSE62254 | GSE15459 | ||||
|---|---|---|---|---|---|---|
| N (%) | TIMP-2 (median, IQR) | P | N (%) | TIMP-2 (median, IQR) | P | |
| Age (median, IQR) | 64 (55–70) | — | 0.047 | 67 (57–73) | — | 0.164 |
| Sex | 0.039 | 0.074 | ||||
| Female | 101 (33.9) | 9.16 (8.62–9.80) | 67 (34.9) | 10.37 (9.78–10.87) | ||
| Male | 197 (66.1) | 8.99 (8.46–9.54) | 125 (65.1) | 10.06 (9.26–10.75) | ||
| Lauren’s | — | 0.020 | ||||
| Intestinal | — | — | 99 (51.6) | 9.93 (9.22–10.70) | ||
| Diffused | — | — | 75 (39.1) | 10.55 (10.00–10.93) | ||
| Mixed | — | — | 18 (9.4) | 9.89 (9.25–10.66) | ||
| T stage | <0.001 | — | ||||
| T1 | — | — | — | — | ||
| T2 | 186 (62.4) | 8.89 (8.38–9.28) | — | — | ||
| T3 | 91 (30.5) | 9.59 (8.89–9.96) | — | — | ||
| T4 | 21 (7.0) | 9.48 (8.66–9.83) | — | — | ||
| N stage | 0.090 | — | ||||
| N0 | 38 (12.8) | 8.79 (8.38–9.34) | — | — | ||
| N1 | 130 (43.6) | 9.04 (8.58–9.49) | — | — | ||
| N2 | 79 (26.5) | 9.07 (8.58–9.74) | — | — | ||
| N3 | 51 (17.1) | 9.16 (8.44–9.87) | — | — | ||
| M stage | 0.021 | — | ||||
| M0 | 271 (90.9) | 9.01 (8.48–9.61) | — | — | ||
| M1 | 27 (9.1) | 9.31 (8.86–10.09) | — | — | ||
| TNM stage | <0.001 | 0.002 | ||||
| I | 30 (10.1) | 8.75 (8.37–9.25) | 31 (16.1) | 9.46 (8.87–10.59) | ||
| II | 96 (32.2) | 8.93 (8.46–9.29) | 29 (15.1) | 9.93 (9.32–10.58) | ||
| III | 95 (31.9) | 9.19 (8.59–9.74) | 72 (37.5) | 10.30 (9.68–10.82) | ||
| IV | 77 (25.8) | 9.31 (8.58–9.92) | 60 (31.2) | 10.56 (9.81–10.92) | ||
IQR, interquartile range.